Biohaven BHVN
NYSE BHVN
$11.77 -0.04 (-0.34%)
As of: Oct 21, 2026 · 3:59 PM EDT

Biohaven (BHVN) Non-Current Debt (2025 - 2026)

Updated

Biohaven's Non-Current Debt was $259.48 million in Q2 2026, up 0.9% from $257.07 million a year earlier and up 7.3% from the prior quarter.

Analysis

Biohaven (BHVN) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Biohaven came in at $238.9 million.

  • Quarterly Non-Current Debt has moved between $238.9 million (Q4 2025) and $268.27 million (Q3 2025) over five years.
  • Per Business Quant data, BHVN's Non-Current Debt in the three quarters before Q2 2026 was $241.91 million (Q1 2026), $238.9 million (Q4 2025) and $268.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Biohaven 1.77 Bn 576.24 Mn - 259.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 259.48 Mn
Mar 31, 2026 241.91 Mn
Dec 31, 2025 238.90 Mn
Sep 30, 2025 268.27 Mn
Jun 30, 2025 257.07 Mn
API Access

Biohaven Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BHVN&period=max&api_key=YOUR_API_KEY